Ocugen, Inc. Form 4 (March 3, 2022)

Summary

Junge Zhang, a director of Ocugen, Inc. [OCGN], reports on this Form 4 two option exercises on March 3, 2022. Zhang exercised an option for 39,000 shares at $0.51 and another for 49,000 shares at $1.83, bringing directly owned common stock to 88,000 shares, with 876,904 shares listed as owned through the Gupiao Trust. Footnotes state the first option initially covered 54,000 shares vesting from February 2, 2020 and the second 126,000 shares vesting from February 1, 2021. The form reports 15,000 and 77,000 derivative securities under the two options after the exercises. Sanjay Subramanian signed as attorney-in-fact on 03/04/2022.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * Zhang Junge (Last) (First) (Middle) 263 GREAT VALLEY PARKWAY (Street) MALVERN PA 19355 (City) (State) (Zip) | Zhang Junge | (Last) | (First) | (Middle) | 263 GREAT VALLEY PARKWAY | MALVERN | PA | 19355 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Ocugen, Inc. [ OCGN ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) | X | Director | 10% Owner | Officer (give title below) | Other (specify below)
3. Date of Earliest Transaction
 (Month/Day/Year) 03/03/2022
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 03/03/2022 | M | 39,000 | A | $ 0.51 | 39,000 | D
Common Stock | 03/03/2022 | M | 49,000 | A | $ 1.83 | 88,000 | D
Common Stock | 876,904 | I | By: Gupiao Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Option (Right to Buy) | $ 0.51 | 03/03/2022 | M | 39,000 | (1) | 01/02/2030 | Common Stock | 39,000 | $ 0 | 15,000 | D
Option (Right to Buy) | $ 1.83 | 03/03/2022 | M | 49,000 | (2) | 01/01/2031 | Common Stock | 49,000 | $ 0 | 77,000 | D
Explanation of Responses:
1. The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. (the "Company") on the applicable vesting dates.
2. The options, initially representing a right to purchase 126,000 shares, vest and become exercisable in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates.
/s/ Junge Zhang by Sanjay Subramanian, his attorney-in-fact | 03/04/2022
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_OCGN_4_filed2022-03-04_0001062993-22-006836.xml

Size

18,463 bytes

SHA-256

7067af63d393b95fb5d50c6d7d7a8e17d81bad4704db43f8770960d262f18d16

Our copy

SEC_OCGN_4_filed2022-03-04_0001062993-22-006836.xml

Original

www.sec.gov